Literature DB >> 22504525

MicroRNAs: key players of normal and malignant myelopoiesis.

Mir Farshid Alemdehy1, Stefan J Erkeland.   

Abstract

PURPOSE OF REVIEW: Recent data show that microRNAs play critical roles in the regulation of the developmental process of hematopoietic stem and progenitor cells toward mature myeloid cells. The main focus of the article is the function of some evolutionary conserved microRNAs that are abundantly expressed and tightly regulated during myelopoiesis. RECENT
FINDINGS: Global microRNA depletion studies in hematopoietic stem cells have shown the importance of microRNA-controlled pathways for hematopoiesis. Recent insights from genetic mouse models and overexpression or deletion of microRNAs in developmental cell intermediates demonstrate strong evidence for evolutionary conserved microRNA-regulated pathways involved in tight control of cellular processes such as proliferation, differentiation and apoptosis at different stages of blood cell development. It is becoming evident that the myeloid transcription factor PU.1 regulates the expression of critical microRNAs including miR-17∼92 and miR-146a during myelopoiesis. Furthermore, there is evidence for the contribution of aberrant miR-125 activities in hematopoietic disorders including myeloid leukemia.
SUMMARY: Despite the large number of articles describing differential microRNA expression during hematopoiesis, microRNA functions and their downstream pathways in myeloid lineage decisions and leukemia are only recently emerging. Here we discuss new findings concerning PU.1-controlled microRNAs and miR-125-regulated networks in normal and malignant myelopoiesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504525     DOI: 10.1097/MOH.0b013e328353d4e9

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  14 in total

1.  A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.

Authors:  Silvia Grassilli; Ervin Nika; Elisabetta Lambertini; Federica Brugnoli; Roberta Piva; Silvano Capitani; Valeria Bertagnolo
Journal:  Cell Oncol (Dordr)       Date:  2016-08-01       Impact factor: 6.730

2.  miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7.

Authors:  Yi Xiao; Changliang Su; Taoran Deng
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

3.  Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells.

Authors:  Y Yan; E A Hanse; K Stedman; J M Benson; X H Lowman; S Subramanian; A Kelekar
Journal:  Cell Death Differ       Date:  2016-02-12       Impact factor: 15.828

4.  Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.

Authors:  Valerie A Morris; Carrie L Cummings; Brendan Korb; Sean Boaglio; Vivian G Oehler
Journal:  Mol Cell Biol       Date:  2015-12-07       Impact factor: 4.272

5.  Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitors.

Authors:  L Vian; M Di Carlo; E Pelosi; F Fazi; S Santoro; A M Cerio; A Boe; V Rotilio; M Billi; S Racanicchi; U Testa; F Grignani; C Nervi
Journal:  Cell Death Differ       Date:  2013-10-18       Impact factor: 15.828

6.  Mir-218 contributes to the transformation of 5-Aza/GF induced umbilical cord mesenchymal stem cells into hematopoietic cells through the MITF pathway.

Authors:  Kaimeng Hu; Chen Xu; Haitao Ni; Zhenyu Xu; Yue Wang; Sha Xu; Kaihong Ji; Jun Xiong; Houqi Liu
Journal:  Mol Biol Rep       Date:  2014-04-03       Impact factor: 2.316

7.  Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression.

Authors:  Mohammadreza Sharifi; Rasoul Salehi; Yousof Gheisari; Mohammad Kazemi
Journal:  Mol Biol Rep       Date:  2014-01-31       Impact factor: 2.316

8.  Stop the dicing in hematopoiesis: what have we learned?

Authors:  Mir Farshid Alemdehy; Stefan J Erkeland
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534

9.  Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.

Authors:  Shi Jinlong; Fu Lin; Li Yonghui; Yu Li; Wang Weidong
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

Review 10.  RUNX1: A microRNA hub in normal and malignant hematopoiesis.

Authors:  Stefano Rossetti; Nicoletta Sacchi
Journal:  Int J Mol Sci       Date:  2013-01-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.